The cyto- and chemoarchitecture of the olfactory bulb of two monotremes (shortbeaked echidna and platypus) was studied to determine if there are any chemoarchitectural differences from therian mammals. Nissl staining in conjunction with enzyme reactivity for NADPH diaphorase, and immunoreactivity for calcium binding proteins (parvalbumin, calbindin and calretinin), neuropeptide Y, tyrosine hydroxylase and non-phosphorylated neurofilament protein (SMI-32 antibody) were applied to the echidna. Material from platypus bulb was Nissl stained, immunoreacted for calretinin, or stained for NADPH diaphorase. In contrast to eutherians, no immunoreactivity for either the SMI-32 antibody or calretinin was found in the mitral or dispersed tufted cells of the monotremes and very few parvalbumin or calbindin immunoreactive neurons were found in the bulb of the echidna. On the other hand, immunoreactivity for tyrosine hydroxylase in the echidna was similar in distribution to that seen in therians, and periglomerular and granule cells showed similar patterns of calretinin immunoreactivity to eutherians. Multipolar neuropeptide Y immunoreactive neurons were confined to the deep granule cell layer and underlying white matter of the echidna bulb and NADPH diaphorase reactivity was found in occasional granule cells, fusiform and multipolar cells of the inner plexiform and granule cell layers, as well as underlying white matter. Unlike eutherians, no NPY immunoreactive or NADPH diaphorase reactive neurons were seen in the glomerular layer. The bulb of the echidna was comparable in volume to prosimians of similar body weight, and its constituent layers were highly folded. In conclusion, the monotreme olfactory bulb does not show any significant chemoarchitectural dissimilarities from eutheria, despite differences in mitral/tufted cell distribution.

1.
Alonso JR, Brinon JG, Crespo C, Bravo IG, Arevalo R, Aijon J (2001) Chemical organization of the macaque monkey olfactory bulb: II Calretinin, calbindin D-28k, parvalbumin, and neurocalcin immunoreactivity. J Comp Neurol 432:389–407.
2.
Ashwell KWS, Hardman CD, Paxinos G (2004) The claustrum is not missing from all monotreme brains. Brain Behav Evol 64:223–241.
3.
Baker H (1986a) Substance P and tyrosine hydroxylase are localized in different neurons of the hamster olfactory bulb. Exp Brain Res 65:245–249.
4.
Baker H (1986b) Species differences in the distribution of substance P and tyrosine hydroxylase immunroeactivity in the olfactory bulb. J Comp Neurol 252:206–226.
5.
Briñón JG, Alonso JR, Arévalo R, Garcia-Ojeda, Lara J, Aijón J (1992) Calbindin D-28k-positive neurons in the rat olfactory bulb. An immunohistochemical study. Cell Tissue Res 269:289–297.
6.
Briñón JG, Alonso JR, Garcia-Ojeda E, Crespo C, Arévalo R, Aijón J (1997) Calretinin- and parvalbumin-immunoreactive neurons in the rat main olfactory bulb do not express NADPH-diaphorase activity. J Chem Neuroanat 13:253–264.
7.
Briñón JG, Martínez-Guijarro FJ, Bravo IG, Arévalo R, Crespo C, Okazaki K, Hidaka H, Aijón J, Alonso JR (1999) Coexpression of neurocalcin with other calcium-binding proteins in the rat main olfactory bulb. J Comp Neurol 407:404–414.
8.
Briñón JG, Weruaga E, Crespo C, Porteros A, Arévalo R, Aijón J, Alonso JR (2001) Calretinin-, neurocalcin-, and parvalbumin-immunoreactive elements in the olfactory bulb of the hedgehog (Erinaceuseuropaeus). J Comp Neurol 429:554–570.
9.
Brunjes PC, Jazaeri A, Sutherland MJ (1992) Olfactory bulb organization and development in Monodelphis domestica (grey short-tailed opossum). J Comp Neurol 320:544–554.
10.
Carrive P, Paxinos G (1994) The supraoculomotor cap: a region revealed by NADPH-diaphorase histochemistry. NeuroReport 5:2257–2260.
11.
Clemens WA (1970) Mesozoic mammalian evolution. Ann Rev Ecol System 1:357–390.
12.
Clemens WA (1979) Notes on the monotremata. In: Mesozoic Mammals: The First Two-Thirds of Mammalian History (Lillegraven JA, Kielan-Jaworowska Z, Clemens WA, eds), pp. 309–311. Berkeley, CA: University of California.
13.
Celio MR (1990) Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35:375–475.
14.
Crespo C, Blasco-Ibáñez JM, Marqués-Mari AI, Martinez-Guijarro FJ (2001) Parvalbumin-containing interneurons do not innervate granule cells in the olfactory bulb. NeuroReport 12:2553–2556.
15.
Davis BJ (1991) NADPH-diaphorase activity in the olfactory system of the hamster and rat. J Comp Neurol 314:493–511.
16.
Gall C, Seroogy KB, Brecha N (1986) Distribution of VIP- and NPY-like immunoreactivities in rat main olfactory bulb. Brain Res 374:389–394.
17.
Gregory JE, Iggo A, McIntyre AK, Proske U (1987) Electroreceptors in the platypus. Nature 326:386–387.
18.
Gregory JE, Iggo A, McIntyre AK, Proske U (1988) Receptors in the bill of the platypus. J Physiol 400:349–366.
19.
Griffiths M (1978) The Biology of the Monotremes. New York, NY, Academic Press.
20.
Hassiotis M, Paxinos G, Ashwell KWS (2004) Cyto- and chemoarchitecture of the cerebral cortex of the Australian echidna (Tachyglossus aculeatus). I. Areal organization. J Comp Neurol 475:495–517.
21.
Hassiotis M, Paxinos G, Ashwell KWS (2005) Cyto- and chemoarchitecture of the cerebral cortex of the Australian echidna (Tachyglossus aculeatus). II. Laminar organization and synaptic density. J Comp Neurol 482:94–122.
22.
Jia C, Halpern M (2004) Calbindin D-28k, parvalbumin, and calretinin immunoreactivity in the main and accessory olfactory bulbs of the gray short-tailed opossum, Monodelphis domestica. J Morphol 259:271–280.
23.
Kakuta S, Oda S, Takayanagi M, Kishi K (1998) Parvalbumin immunoreactive neurons in the main olfactory bulb of the house musk shrew, Suncus murinus. Brain Behav Evol 52:285–291.
24.
Kosaka K, Heizmann CW, Kosaka T (1994) Calcium binding protein parvalbumin-immunoreactive neurons in the rat olfactory bulb. 1. Distribution and structural features in adult rat. Exp Brain Res 99:191–204.
25.
Ksiezak-Reding H, Dickson DW, Davies P, Yen SH (1987) Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. Proc Natl Acad Sci USA 84:3410–3414.
26.
Lee VM, Otvos L, Carden MJ, Hollosi M, Dietzschold B, Lazzarini RA (1988) Identification of the major multiphosphorylation site in mammalian neurofilaments. Proc Natl Acad Sci USA 85:1998–2002.
27.
Manger PR, Fahringer HM, Pettigrew JD, Siegel JM (2002) The distribution and morphological characteristics of catecholaminergic cells in the brain of monotremes as revealed by tyrosine hydroxylase immunohistochemistry. Brain Behav Evol 60:298–314.
28.
Matsutani S, Senba E, Tohyama M (1989) Distribution of neuropeptidelike immunoreactivities in the guinea pig olfactory bulb. J Comp Neurol 280:577–586.
29.
Musser A (2003) Review of the monotreme fossil record and comparison of paleontological and molecular data. Comp Biochem Physiol Part A 136:927–942.
30.
Nakajima T, Okamura M, Ogawa K, Taniguchi K (1996) Immunohistochemical and enzyme histochemical characteristics of short axon cells in the olfactory bulb of the golden hamster. J Vet Med Sci 58:903–908.
31.
Ohm TG, Braak E, Probst A, Weindl A (1988) Neuropeptide Y-like immunoreactive neurons in the human olfactory bulb. Brain Res 451:295–300.
32.
Paxinos G, Kus L, Ashwell KWS, Watson CRR (1999) Chemoarchitectonic atlas of the rat forebrain. San Diego, CA, Academic Press.
33.
Ramón y Cajal S (1955) Studies on the Cerebral Cortex (limbic structures). London, Lloyd-Luke.
34.
Sanides-Kohlrausch C, Wahle P (1990) Morphology of neuropeptide Y-immunoreactive neurons in the cat olfactory bulb and olfactory peduncle: Postnatal development and species comparison. J Comp Neurol 291:468–489.
35.
Scheich H, Langner G, Tidemann C, Coles RB, Guppy A (1986) Electroreception and electrolocation in platypus. Nature 319:401–402.
36.
Schwaller B, Buchwald P, Blumcke I, Celio MR, Hunziker W (1993) Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin. Cell Calcium 14:639–648.
37.
Scott JW, McDonald JK, Pemberton JL (1987) Short axon cells of the rat olfactory bulb display NADPH-diaphorase activity, neuropeptide Y-like immunoreactivity, and somatostatin-like immunoreactivity. J Comp Neurol 260:378–391.
38.
Smith RL, Baker H, Kolstad K, Spencer DD, Greer CA (1991) Localization of tyrosine hydroxylase and olfactory marker protein immunoreactivities in the human and macaque olfactory bulb. Brain Res 548:140–148.
39.
Stephan H, Bauchot R, Andy OJ (1970) Data on the size of the brain and of various brain parts in insectivores and primates. In: The Primate Brain. Advances in Primatology (Noback CR, Montagna W, eds) Vol 1, pp 289–297. New York: Appleton-Century-Crofts.
40.
Sternberger LA, Sternberger NH (1983) Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci USA 80:6126–6130.
41.
Switzer RC, Johnson JI (1977) Absence of mitral cells in monolayer in monotremes. Variations in vertebrate olfactory bulbs. Acta Anat 99:36–42.
42.
Toida K, Kosaka K, Heizmann CW, Kosaka T (1996) Electron microscopic serial-sectioning/reconstruction study of parvalbumin-containing neurons in the external plexiform layer of the rat olfactory bulb. Neuroscience 72:449–466.
43.
Wouterlood FG, Hrtig W (1995) Calretinin-immunoreactivity in mitral cells of the rat olfactory bulb. Brain Res 682:93–100.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.